Guardant Health, Inc. (NASDAQ:GH) stock is trading higher on Tuesday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation to the company’s Shield multi-cancer ...
The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine continue to reshape how diseases are detected and managed. Within this landscape ...
On Thursday, Guardant Health (NYSE:GH) reported fourth-quarter adjusted EPS loss of 62 cents, compared to a loss of 64 cents a year ago, beating the consensus loss of 74 cents. The cancer diagnostic ...
We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Guardant Health, Inc. is one of them. Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, ...
Guardant Health, Inc. (NASDAQ:GH) and research collaborators have unveiled results from the largest study to date on circulating tumor DNA (ctDNA) testing in stage III colon cancer, presented at the ...
NASHVILLE, Tenn. & TAMPA, Fla.--(BUSINESS WIRE)--Reimagine Care, the leader in on-demand, technology-enabled cancer care, today announced a collaboration with the Tampa General Hospital (TGH) Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results